AstraZeneca can send its representatives to Georgia to study the issue of the 27-year-old nurse from Akhaltsikhe. Such a statement made today the Head of the National Center for Disease Control.

“In the case of this type of fatal complication, there is an established rule, in Sweden there is a world center for drug side effects and the regulatory agency sends the information to them. AstraZeneca, the World Health Organization, will also be notified when the investigation is completed.

First a short report is sent, then a more extensive one. Their representatives often come and study the situation on the spot, and this is not ruled out in this case”, - said Amiran Gamkrelidze.